Clinical Evaluation of VirtualDose - a Software for Tracking and Reporting CTDI, DLP, Organ and Effective Dose for Adult and Pediatric Patient
A Ding1*, Y Gao1, P Caracappa1, D Long2, W Bolch2, B Liu3, M Kalra,3, X Xu1, (1) Rensselaer Polytechnic Institute, Troy, NY, (2) University of Florida, Gainesville, Florida, (3) Massachusetts General Hospital, Boston, MATU-G-103-2 Tuesday 4:30PM - 6:00PM Room: 103
To update the development and clinical testing of a new Software as a Service (SaaS) -VirtualDose for tracking and reporting CT doses.
VirtualDose has been developed as a CT dose reporting SaaS by offering a web-based dynamic user-friendly interface. Based on the user-specified scanning parameters, VirtualDose rapidly report the organ dose data from the remote server-side database and interactively tabulate and plot the results of interest within a web browser. Clinical testing found the dose up to 24% different as compared to those derived from the stylized MIRD-type phantoms. The morbidly obese phantom received up to 60% smaller CT dose than that of the normal weight phantom
VirtualDose is now available in the following website: http://www.virtualphantoms.com and being tested at more than 20 medical centers nationwide. Using a large library of adult and pediatric phantoms, it provides more accurate dose data and is expected to improve both the accuracy and usability in CT dose reporting in the future.
Add this talk to vcal | ical | Contact Email: